NASDAQ: CAPR
Capricor Therapeutics Inc Earnings Dates, Reports, Calls

Capricor Therapeutics earnings were -$129.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CAPR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$40.7M, up 20% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CAPR reported annual earnings of -$105.0M, with 159.6% growth. The next CAPR earnings date is Nov 9, 2026.

CAPR earnings history

Current Revenue
$0.0
Current Earnings
-$129.4M
Current Profit Margin
0%

CAPR Return on Equity

Current Company
-56.6%
Current Industry
-13.6%
Current Market
30.9%
CAPR's Return on Equity (-56.6%)... subscribe to Premium to read more.
High Return on Equity Performance

CAPR Return on Assets

Current Company
-44%
Current Industry
-10.3%
CAPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CAPR announces earnings.

CAPR Return on Capital Employed

Current Company
-37.63%
Current Industry
-7%
CAPR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CAPR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CAPR-$124.27M-$129.42MN/A-$2.45
TECX-$82.14M-$85.79MN/A-$4.57
OVID-$33.17M-$34.49MN/A-$0.23
RGNX-$139.12M-$196.43MN/A-$3.79
DNA-$209.98M-$290.80MN/A-$5.01

CAPR earnings dates

Next earnings date
Nov 9, 2026

Capricor Therapeutics Earnings Reports & History FAQ

What were Capricor Therapeutics's earnings last quarter?

On CAPR's earnings call on Aug 17, 2026, Capricor Therapeutics (NASDAQ: CAPR) reported Q2 2026 earnings per share (EPS) of -$0.70, up 22.81% year over year. Total CAPR earnings for the quarter were -$40.73 million. In the same quarter last year, Capricor Therapeutics's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.

When does Capricor Therapeutics report earnings?

The next CAPR earnings date is Nov 9, 2026. Add CAPR to your watchlist to be reminded of Capricor Therapeutics's next earnings date.

Is Capricor Therapeutics profitable or losing money?

As of the last Capricor Therapeutics earnings report, Capricor Therapeutics is currently losing money. Capricor Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$129.42 million, a 84.94% increase year over year.

What was CAPR's earnings growth in the past year?

As of Capricor Therapeutics's earnings date in Aug 17, 2026, Capricor Therapeutics's earnings has grown year over year. CAPR earnings in the past year totalled -$129.42 million.

What are Capricor Therapeutics's earnings expectations?

The current EPS estimate for Capricor Therapeutics's earnings report in Nov 9, 2026 is -$0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.